Interview with Sebastien Burel, PhD
Sebastien Burel, PhD Ionis Pharmaceuticals Director Nonclinical Development How did you become interested in the field of oligonucleotides? Mostly by accident.
OTS2022-09-24T05:00:48+00:00January 3rd, 2017|Categories: Featured Members|
Sebastien Burel, PhD Ionis Pharmaceuticals Director Nonclinical Development How did you become interested in the field of oligonucleotides? Mostly by accident.
Oligonucleotide Therapeutics Society
3960 W Point Loma Blvd, Suite H
Box 346
San Diego, CA 92110
info@oligotherapeutics.org
© Copyright 2012 – 2024 | Oligotherapeutics.org | All Rights Reserved | Finfrock Marketing